000 01258 a2200337 4500
005 20250518095255.0
264 0 _c20210514
008 202105s 0 0 eng d
022 _a2473-9537
024 7 _a10.1182/bloodadvances.2019000874
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRambaldi, Alessandro
245 0 0 _aBlinatumomab consolidation and maintenance therapy in adults with relapsed/refractory B-precursor acute lymphoblastic leukemia.
_h[electronic resource]
260 _bBlood advances
_c04 2020
300 _a1518-1525 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAntibodies, Bispecific
_xtherapeutic use
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aConsolidation Chemotherapy
650 0 4 _aHumans
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xdrug therapy
700 1 _aHuguet, Francoise
700 1 _aZak, Pavel
700 1 _aCannell, Paul
700 1 _aTran, Qui
700 1 _aFranklin, Janet
700 1 _aTopp, Max S
773 0 _tBlood advances
_gvol. 4
_gno. 7
_gp. 1518-1525
856 4 0 _uhttps://doi.org/10.1182/bloodadvances.2019000874
_zAvailable from publisher's website
999 _c30856195
_d30856195